Literature DB >> 4824504

Venezuelan equine encephalitis virus infection in man.

N J Ehrenkranz, A K Ventura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4824504     DOI: 10.1146/annurev.me.25.020174.000301

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  17 in total

1.  Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.

Authors:  Slobodan Paessler; Haolin Ni; Olga Petrakova; Rafik Z Fayzulin; Nadezhda Yun; Michael Anishchenko; Scott C Weaver; Ilya Frolov
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

2.  Replication of alphaviruses in cultures of donkey monocytes.

Authors:  F Liprandi; B Gómez; R Walder
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

3.  Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus.

Authors:  Shannon S Martin; Russell R Bakken; Cathleen M Lind; Patricia Garcia; Erin Jenkins; Pamela J Glass; Michael D Parker; Mary Kate Hart; Donald L Fine
Journal:  Vaccine       Date:  2010-03-01       Impact factor: 3.641

4.  Venezuelan Equine Encephalitis Virus V3526 Vaccine RNA-Dependent RNA Polymerase Mutants Increase Vaccine Safety Through Restricted Tissue Tropism in a Murine Model.

Authors:  Clint A Haines; Rafael K Campos; Sasha R Azar; K Lane Warmbrod; Tiffany F Kautz; Naomi L Forrester; Shannan L Rossi
Journal:  Zoonoses (Burlingt)       Date:  2022-01-13

5.  Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule.

Authors:  Janice M Rusnak; Lesley C Dupuy; Nancy A Niemuth; Andrew M Glenn; Lucy A Ward
Journal:  Comp Med       Date:  2018-10-03       Impact factor: 0.982

6.  Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.

Authors:  Slobodan Paessler; Rafik Z Fayzulin; Michael Anishchenko; Ivorlyne P Greene; Scott C Weaver; Ilya Frolov
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

7.  The 5'UTR-specific mutation in VEEV TC-83 genome has a strong effect on RNA replication and subgenomic RNA synthesis, but not on translation of the encoded proteins.

Authors:  Raghavendran Kulasegaran-Shylini; Varatharasa Thiviyanathan; David G Gorenstein; Ilya Frolov
Journal:  Virology       Date:  2009-03-17       Impact factor: 3.616

8.  Interaction of alphaviruses with human peripheral leukocytes: in vitro replication of Venezuelan equine encephalomyelitis virus in monocyte cultures.

Authors:  N H Levitt; H V Miller; R Edelman
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

9.  Serologic evidence of widespread everglades virus activity in dogs, Florida.

Authors:  Lark L Coffey; Cynda Crawford; James Dee; Ryan Miller; Jerome Freier; Scott C Weaver
Journal:  Emerg Infect Dis       Date:  2006-12       Impact factor: 6.883

10.  Synthesis and biological activity of conformationally restricted indole-based inhibitors of neurotropic alphavirus replication: Generation of a three-dimensional pharmacophore.

Authors:  Scott J Barraza; Janice A Sindac; Craig J Dobry; Philip C Delekta; Pil H Lee; David J Miller; Scott D Larsen
Journal:  Bioorg Med Chem Lett       Date:  2021-06-15       Impact factor: 2.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.